Sanders Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,073,420
| Closed | -$104M | – | 46 |
|
|
2023
Q3 | $104M | Buy |
1,073,420
+710
| +0.1% | +$72.1K | 0.22% | 30 |
|
|
2023
Q2 | $108M | Sell |
1,072,710
-57,820
| -5% | -$5.78M | 0.23% | 32 |
|
|
2023
Q1 | $104M | Buy |
1,130,530
+670
| +0.1% | +$58.5K | 0.25% | 31 |
|
|
2022
Q4 | $103M | Sell |
1,129,860
-1,820
| -0.2% | -$153K | 0.27% | 30 |
|
|
2022
Q3 | $86M | Sell |
1,131,680
-1,740
| -0.2% | -$144K | 0.24% | 29 |
|
|
2022
Q2 | $95.8M | Sell |
1,133,420
-3,220
| -0.3% | -$282K | 0.24% | 29 |
|
|
2022
Q1 | $99.7M | Buy |
+1,136,640
| New | +$98.4M | 0.22% | 30 |
|
|
2016
Q4 | – | Sell |
-2,120
| Closed | -$150K | – | 43 |
|
|
2016
Q3 | $150K | Sell |
2,120
-1,898
| -47% | -$138K | ﹤0.01% | 44 |
|
|
2016
Q2 | $297K | Sell |
4,018
-1,004
| -20% | -$69.4K | ﹤0.01% | 46 |
|
|
2016
Q1 | $326K | Hold |
5,022
| – | – | ﹤0.01% | 47 |
|
|
2015
Q4 | $387K | Hold |
5,022
| – | – | ﹤0.01% | 46 |
|
|
2015
Q3 | $414K | Hold |
5,022
| – | – | ﹤0.01% | 46 |
|
|
2015
Q2 | $443K | Hold |
5,022
| – | – | ﹤0.01% | 46 |
|
|
2015
Q1 | $444K | Hold |
5,022
| – | – | ﹤0.01% | 46 |
|
|
2014
Q4 | $417K | Hold |
5,022
| – | – | ﹤0.01% | 49 |
|
|
2014
Q3 | $424K | Hold |
5,022
| – | – | ﹤0.01% | 49 |
|
|
2014
Q2 | $407K | Buy |
5,022
+112
| +2% | +$8.81K | ﹤0.01% | 52 |
|
|
2014
Q1 | $374K | Hold |
4,910
| – | – | ﹤0.01% | 53 |
|
|
2013
Q4 | $354K | Hold |
4,910
| – | – | ﹤0.01% | 54 |
|
|
2013
Q3 | $338K | Hold |
4,910
| – | – | ﹤0.01% | 52 |
|
|
2013
Q2 | $311K | Buy |
+4,910
| New | +$319K | ﹤0.01% | 51 |
|
Other funds holding NVS
